The Discounted Cash Flow (DCF) valuation of Hikma Pharmaceuticals PLC (HIK.L) is 1,207.03 GBP. With the latest stock price at 1,934.00 GBP, the upside of Hikma Pharmaceuticals PLC based on DCF is -37.6%.
| Range | Selected | |
| WACC / Discount Rate | 7.8% - 10.0% | 8.9% |
| Long-term Growth Rate | 1.0% - 3.0% | 2.0% |
| Fair Price | 863.63 - 1,846.28 | 1,207.03 |
| Upside | -55.3% - -4.5% | -37.6% |